We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
+47.8%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.1M
AUM Growth
+$19.9M
Cap. Flow
-$4.8M
Cap. Flow %
-5.04%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AKBA icon
Akebia Therapeutics
AKBA
+$4.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
1
Annexon
ANNX
$995M
$53.1M 55.85%
7,406,024
– –
AKBA icon
2
Akebia Therapeutics
AKBA
$260M
$24.2M 25.42%
13,205,119
-3,000,000
-19% -$4.8M
AMWL icon
3
American Well
AMWL
$200M
$8.49M 8.93%
523,786
– –
RNTX
4
Rein Therapeutics
RNTX
$67.5M
$5.51M 5.79%
830,466
– –
WHWK
5
Whitehawk Therapeutics
WHWK
$278M
$3.82M 4.01%
1,630,830
– –

Similar funds

LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54M AUM
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
AFA
Atlas Financial Advisors Oroville, California $64.1M AUM 8.36% 1-Year Est. Return
MCC
Maiden Cove Capital Cape Elizabeth, Maine $65.4M AUM
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
MC
Meketa Capital Westwood, Massachusetts $44.6M AUM
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Alerce Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Alerce Investment Management held 5 positions worth $95.1M, up 27% from $75.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alerce Investment Management withdrew a net $4.8M in Q1 2024, reducing 1 holding. Its largest reduction was Akebia Therapeutics, cutting an estimated $4.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's biggest Q1 2024 reduction was Akebia Therapeutics, cutting an estimated $4.8M.
  • Alerce Investment Management's ten largest holdings make up 100% of its $95.1M portfolio in Q1 2024.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q1 2024.
  • Alerce Investment Management's portfolio value rose 27% quarter-over-quarter to $95.1M.

Based on Alerce Investment Management's 13F filing for Q1 2024, filed 9 May 2024.